mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
0.002 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.003 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.004 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.007 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.007 |